Parker Flashcards
ASA Grades
1 - normal healthy individual
2- mild systemic disease that does not limit activity
3- severe systemic disease that limits activity but is not incapacitating
4- incapacitating systemic disease which is constantly life threatening
5- moribund, not expected to survive 24hrs with/without op
c.50% of elective patients = ASA 1
Op mortality = <1 in 10,000
POSSUM Scoring
Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity
developed in a general surgical pop and has been adapted for vascular, colorectal and oesophago-gastric patients
12 physiological and biochemical variables + 6 operative variables => estimated mortality risk
risk adjusted assessment of surgical quality and accurately predicts 30 day morbidity and mortality
Elective surgery grades
graded in accordance to the degree if stress it will cause
- Minor - e.g. excision of skin lesion
- Intermediate - e.g. inguinal hernia repair
- Major - e.g. hysterectomy
- Major plus - e.g. colonic resection
The FEV1/FVC ratio is the ratio of the forced expiratory volume in the first one second to the forced vital capacity of the lungs.
The normal value for this ratio is above 0.75-85, though this is age dependent.
<0.70 = airflow limitation = obstructive pattern
restrictive lung diseases often produce a FEV1/FVC ratio which is either normal or high with a reduced FVC
CV disease scoring e.g. Revised cardiac risk index
- High-risk surgery
- IHD
- Hx of CCF
- Hx of CVD
- Insulin therapy for GM
- Renal impairment
risk of major cardiac event 0.5% for zero points, 10% for more than 2 points
Risk factors for post op MreI
elective op should be deferred for 6mo post MI
Risk for post op re-infarction:
- Short time since previous infarct
- 0-3mo = 35%
- 3-6mo = 15%
- >6mo = 4%
- residual major coronary vessel disease
- prolonged/major surgery
- impaired myocardial function
c.60% post op MIs = silent
Mortality = c.40%
Complications associated with obesity:
- CV: HTN, IHD, CVD, DVT, difficult vascular access
- Respiratory: Difficult airway, difficult mechanical vent, chronic hypoxaemia, OSA, Pulmonary HTN, Post op Hypoxaemia
- Other: GORD, Abn liver runction, insulin resistance, T2DM, poor post op pain control, unpredictable pharmacological response
Complications associated with CKD:
- electrolyte disturbances
- impaired acid-base balance
- anaemia
- coagulopathy
- impaired autonomic regulation
- protection of veins, shunts, fistulas
When obstaining informed consent patients should be informed of:
- Detailed of diagnosis
- Uncertainties about the diagnosis
- Options available for treatment
- Proposed purpose of procedure
- Prognosis with and without procedure
- Likely benefits and probability of success
- possible side effects
- reminder that patient can change their mind at any stage
- reminder that patients have the right to a second opinion
All Qs should be answered honestly, info should not be witheld which might influence the decision, patient should not be coerced, person who obtains consent must be suitably trained and qualified, they must have sufficient knowledge of the proposed Rx and risks, good practice for this to be the physician provising the treatment
Consent forms 1-4
- Consent Form 1 - Patient agreement to investigation or treatment
- Consent Form 2 - Parental agreement to investigation or treatment
- Consent Form 3 - Patient/parental agreement to investigation or treatment (procedures where consciousness not impaired)
- Consent Form 4 - Form for adults who are unable to consent to investigation or treatment
Consent forms 5-9
- Consent Form 5 - Patient Agreement to Anti-cancer treatment
- Consent Form 6 - Supplementary Consent for Gifting of Tissue
- Consent form 7 - Consent to photography and conventional or digital video recordings form.
- Consent Form 8 - Consent for hospital post mortem examination on an adult
- Consent Form 9 - Consent for hospital post mortem examination on a baby or child
Consent in children
at 16yrs a child can be presumed to have capacity to decide on treatment
below the age of 16 a child may have the capacity to decide depending on their ability to undeerstand what the treatment involved (Gillick)
If a competent child refuses treatment a person which parental responsibility may authorise treatment which is in the child’s best interest
Mental capacity act
under the MCA a person is presumed to make their own decisions ‘unless all practical steps to help him/her have been taken without success.
Incapacity is not based on the ability to make a wise/sensible decision to determine
- is there an impairment or disturbance in the function of their mind/brain or an inability to make decision
A person is unable to make a decision is they:
- cannot understand the information relevant to the decision
- they are unable to retain that information
- they are unable to use/weigh that information as part of the decision making process
- they are unable to communicate the decision
If, having taken all practical steps to assist someone, it is concluded that a decision should be made for a person the decision must be made in that person’s best interest therefore…
- do not make assumptions on the basis of age, appearance, condition or behaviour
- consider all relevant circumstances
- consider whether/when the pt will have capacity
- support the pt’s participation in any acts/decisions made for them
- do not make a decision about life sustaining Rx motivated by a desire to bring about death
- consider the pts expressed wishes, feelings, beliefs, values
- take into account the views of others with an interest in the person’s welfare, their carers and those appt to act on their behalf
What risk assessment models fo you know?
- Goldman cardiac risk index
- parsonnet score
- POSSUM
- Injury severity score
- Revised trauma score
- APACHE I, II, III
WHO Safe surgery check list
- address preventable human error through a series of checks: sign in, time out, sign out, prior/during/after surgical procedure
- aims to strengthen the commitment of clinical staff to address safety issues within the surgical setting
- incl - improving anaesthetic safety practices, ensure correct site surgery, avoid surgical infections, improves communication within teams
- shown to reduce risk of complications and death
What is pharmacokinetics
study of the bodily absorption, distribution, metabolism and excretion of drugs
What is pharmacodynamics
study of the biochemical and physiological effects of drugs and their mechanisms of actions
General anaesthesia
drug induced state of unresponsiveness usually achieved by the use of a combination of agents
3 phases: induction, maintenance, reversal and recovery
GA: premedications
- Amxiolysis - benzodiazepines, phenothiazines
- analgesia - opiates, non-steroids anti-inflammatories
- Amnesia - benzodiazepines, anticholinergics
- Antiemetics - anticholinergics, antihistamines, 5HT antagnosits
- Antacids = alginates, PPIs
- Anti-autonomic - anticholinergics, B Blockers
- Adj - bronchodilators, steroids
Induction agents
IV, highly lipid soluble, rapidly cross BBB, distributed to organs with high bld flow e.g. brain, rapidly redistributed -> rapid onset/recovery
- thiopentone - short acting barbituate
- depresses myocardium and in hypovolaemic pt -> profound hypotension
- propofol - most commonly uses
- short 1/2 life, causes hypotension
- used as an infusion for maintenance
- no analgesic properties, used with opioids e.g. fentanyl
What is RSI
Rapid sequence induction = rapid induction of anaesthesia
Cricoid pressure -> reduces the risk of aspiration
pressure is released once definitive airway is achieved
e.g. thiopentone & suxamethonium
Pt who are not fastes/ Hx of GORD/Intestinal obstruction/pregnancy/intra-abdo pathology
Benefits/complications of ET airway
ET = placement of a tube into the trachea to maintain a patent airway
- Benefits:
- Protection against aspiration and gastric insufflation
- Effective ventilation and oxygenation
- Facilitation of suctioning
- Delivery of anaesthetic and other drugs
- Complications:
- Failed intubation -> hypoxaemia
- Right mainstem inbutation
- Oesophageal intubation
- trauma from laryngoscope to teeth/soft tissues
- Vocal cord damage
- Aspiration and post intubation pneumonia
- pneumothorax
- Hypotension and arrythmias
What are the 3 aspects of anaesthesia?
- Hypnosis - suppression of consciousness
- Analgesia - suppression of physiological responses to stimuli
- Relaxation - suppression of muscle tone and relaxation
Wha are the ideal features of an inhalational anaesthetic agent
inhaled volatile gases, lipid soluble hydrocarbons, high saturated vapour pressures
Potent, non-inflammable, non-explosive
- Easily administered
- boiling point above ambient temp
- low latent heat of vaporisation
- chemically stable with long shelf life
- compatible with soda-limb, metals, plastics
- non-flammable
- cheap
- Phamacokinetic
- low solubility
- rapid onset, offset, adj depth
- minimal metabolism
- predictable in all age groups
- Pharmacodynamic
- high potency- allows high FiO2
- High therapeutic index
- Analgesic
nb MAC - Minimal Alveolar Concentration = alveolar conc required to keep 50% of pop unresponsive
Halothane
potent anaesthetic but poor analgesic agent
MAC = 0.75
20% metabolised in liver
can cause hepatic dysfunction, occasionally causes severe hepatitis, can progress to liver necrosis
Depresses myocardial contractility and can induce arrythmias
Isoflurane
potent anaesthetic but poor analgesic agent
MAC = 1.05
Less cariotoxic than halothane
More resp depression than halothan
reduces peripheral resistance and can cause coronary steal
Few adverse effects reported
Nitrous oxide
Weak anaesthetic agent, cannot be used alone without causing hypoxia
potent analgesic agent
50% N2O/50%O2 = Entonox
Used in anaesthesia for it’s analgesic properties
What are the adverse effects of inhalation anaesthetic ?
- Cardiovascular:
- Decrease myocardial contractility
- reduced cardiac output
- hypotension
- arrhythmias
- Increased myocardial sensitivity to catecholamies
- Respiratory:
- depress ventilation
- laryngospasm and airway obstruction
- decrease ventilatory response to hypoxia & hypercapnia
- bronchodilatation
- CNS
- increase cerebral blood flow
- reduce cerebral metabolic rate
- increase risk of epilepsy
- increase iintracranial pressure
- Other
- decrease renal blood flow
- simulate nausea and vomiting
- precipirate hepatitis
GA: Muscle relaxants
either depolarising or non depolarising
Depolarising (e.g. suxamethonium)
- act rapidly within seconds and their effects last for c.5mins
- used during induction of anaesthesia
- SE:
- Histamine release = ‘scoline rash’
- Bradycardia
- Somatic pain from fasciculation
- Hyperkalaemia
- Increased intra-ocular pressure
- Increased gastric pressure
- Severe complications:
- 1:7000, persistent neuromuscular blockage -> ‘scoline apnoea’, due to pseudocholinesterase deficiency
- 1:100,000, increased Ca influx, uncontrolled metabolism -> increased Ca influx and uncontrolled metabolism -> increased body temp with increasing PCO2 -> Malignant hyperpyrexia
Non-depolarising (e.g. vecuronium) act over 2-3mins, effects last 30mins - 1hr, competitive antagonists of acetylcholine receptor, used for intra-op muscle relaxation
Anaesthetist - peri-op monitoring
- maintain the airway & oxygenation
- manual, guedel, LMA, ETT, Tracheostomy T
- preserve circulation
- prevent hypothermia
- prevent injury
- monitor during anaesthesia
e.g.:
- Always: Temp/HR/BP/ECG/O2 of inspiratory gas mix/Ent tital CO2/Pulse oximetry
- Consider: Invesive BP monitoring, Central venous pressure, Urine output
Arterial pressure monitoring
Requires:
- arterial cannula
- monitoring line
- transducer
- monitoring system
Provide info on systolic and diastolic pressure & arterial waveform
Complications/problems:
- Over and under dampening
- incorrect zeroing
- haematoma
- distal ischaemia
- inadvertent drug injection
- disconnection and haemorrhage
- infection
Central Venous Pressure
Cannulation of central venous system by internal jugular or subclavian routes -> more accurate info re CVP and intravascular volume (&cardiac pre-load)
Complications:
- pneumothorax
- arterial puncture
- air embolism
- infection
Swan-Ganz catheter
Balloon tipped catheter inserted through central vein, through right heart into pulmonary artery, bloon alow weding in a branch of the pulmonary artery = pulmonary capillary wedge pressure = left atrial pressure
Tip contains a thermistor
CO - measured using themodilution principal
Complications:
- arrhythmias
- knotting and misplacement
- cardial valve trauma
- pulmonary infarction
- pulmonary artery rupture
- balloon rupture
- catheter thrombosis or embolism
Primary haemodynamic date obtained from S-G includes:
- HR, MAP, CVP, Mean pulmonary artery pressure, mean pulmonary artery occlusion pressure, cardiac output, ventricular ejection fraction
Data derived from this:
- Cardiac index, stroke volume, stroke volume index, systemic vascular resistance, systemic vascular resistance index, pulmonary vascular resistance index, left ventricular stroke work index, right ventricular stroke work index, oxygen delivery, oxygen consumption
Recovery from anaesthesia: cause of failure to breath post anaesthetic
- obstruction of airway
- central sedation due to opiates/anaesthetic agent
- hypoxia
- hypercarbia
- hypocarbia due to overventilation
- persistent neuromuscular blockade
- pneumothorax
- circulatory failure leading to resp arrest
Common intra-operative nerve injuries?
- Ulnar nerve - resting arms in pronation alongside the patient (medial epicondyle and operating table)
- Brachial plexus - arms in abduction (>60) and external rotation
- Common peroneal nerve - lithotomy position (fibula head and table)
- Radian nerve - tourniquet/misplaced injection in deltoid muscle
Plasma
Fluid component of blood - 55%
pH 7.34-7.45
90% water, 10% solutes
Solutes = Albumin 60%, globulins 35%, fibrinogen, thrombin, hormones, chloesterol, nitrogenous wastes, nutrients, electrolytes
Erythrocytes
biconcave discs 7.5um in diameter
formed in bone marrow and removed from circulation in the liver/spleen
no nuclei or mitochondria
life span 120 days
red cell production requires: iron, amino acids, vitamins, hormones, - erythropoietin
Reticulocytes = immature red cells
1-2% of circ
Red cell production is stimulated by - H’gge, anaemia, hypoxia, increased O2 requirement
Leukocytes
1% of blood volume
nuclei and mitochondria
5 types:
- neutrophils 40-70%
- phagocytosis - bacteria
- lymphocytes 20-40%
- produced in LN/spleen
- B=antibodies, T=cell mediated immunity NK = immune surveillance
- monocytes 4-8%
- precursors of tissue machrophages
- basophils 1%
- histamine, chemotactic agents
- Eosinophils
- parasites, immune complex destruction
Platelets
fragments of megakaryocytes
bone marrow
life span = 10 days
granules contain; Ca, ADP, serotonin, platelet derived frowth factor
Role in blood coagulation
Iron Metabolism
Body contains c.5g of iron
65% of body’s iron is in Hb, 30% in ferritin and haemosiderin, 3% myoglobin
Daily dietary requirement = 1mg (man), 3mg (woman), average diet contains c.15mg, in ferric hydroxide and ferric-protein complexes e.g. liver and meat, c.5-10% of dietary iron is absorbed, in ferrous (2+) form and enters plasma in the ferric form, in duodenum and jejunum. Absorption is increased in pregnancy and iron deficiency states, controlled in epithelial cells. excess iron forms ferritin and is shed with cells in the gut lumen
Iron is bound to transferrin in the portal bloods and carried to the bone marrow where it is mainly used for Erythropoiesis. c.6g of haemoglobin are produced each day requiring c.20mg of iron. Total plasma turns over c.7x/day
Iron is storre bound to reffitin and haemosiderin
Ferritin
water soluble protein iron complex
composed of apoferritin and iron-phosphate-hydroxide core
20% of its weight is iron
synthesis is stimulated by the presence of iron
iron is in the ferric (3+) form
Haemosiderin
insolube protein-iron complex
40% of it’s weight = iron
formed by lysosomal digestion of ferritin
Transferrin
B-globulin synthesised in the liver
Iron Deficiency Anaemia
Commonest cause of anaemia worldwide
Hypochromic and microcytic red blood cells
Sx= lethargy, dyspnoea, skin atrophy, koilonychia, angular stomatitis, glossitis, oesophageal/pharyngeal webs
Causes:
- Increase loss - uterine, GI, urine
- Increased demands - prematurity, growth, child bearing
- Malabsorption - post gastrectomy, coeliac disease
- Poor diet
Investigation:
- FBC - Hb M<13.5, W<11.5, MCV <76, MCH <27, MCH conc <300
- Blood film - microcytic, hypochromic red cells
- other causes: anaemic of chronic disease, thalassaemia trait, sideroblastic anaemia
- haematinic assay (serum ferritin <10, iron M<14, W<11, vitamin B12, folate)
- Faecal occult blood
- Mid-stream urine
- Endoscopic or radiological studies of GI tract
Management:
- Oral replacement; ferrous sulphate, fumarate gluconate
- 200mg of iron/day
- SE: epigastric pain, constipation, diarrhoea
- aim: increase Hb conc 1g/L/dau. continue for 3 mo post normal Hb achievement
- IV iron - if oral not tolerated
- SE: anaphylaxis, skin staining, arthralgia
Sickle cell
AR - single amino acid substitution in B chain, Valine-> glutamic acid at position 6, Homozygous = Sickle cell disease, heterozygous = sickle cell trait, Hb S = less soluble than Hb A & when deoxygenated -> polymerisation -> sickle cells -> blockage of small vessels -> vaso-occlusive event. Sicking precipitated by infection, fever, dehydration, cold, hypoxia. Blood film = chronic haemolytic anaemia with high reticulocyte count, @risk of infection by encapsulated bacteria
Acute complications:
- Painful crisis
- 60% of pt have 1 episode/yr, bony crisis = localised ischaemia ?AVN, rest and analesia. Abdo crisis = abdo pain, vomiting, distension, features of peritonism. c.40% adolescence with SCD have gallstones
- worsening anaemia
- due to acute splenic sequestration/aplastic crisis PC: tiredness, cardiac failure, URGENT transfusion
- acute chest symptoms
- CP, cough, fever, tachypnoea XR=consolidation. Chlamydia/mycoplasma = important causes of chest infection. Mx = parenteral ABx
- symptoms and signs of neurological/ocular events
- stroke in c.10% of pt <20yrs, Acute stroke -> URGENT exchange transfusion
- priapism
- 20% before 20 yrs, if >few hrs-> impotence. Mx - blood aspirated from copura. Intra-cavernosal injection of alpha agonist e.g. phylepherine
Investigation/diagnostics:
- sickle solubility test
- high performance liquid chromatography
Patient should avoid cold, dehydration, take prophylacitc ABx (phenoxymethylpenicillin & vaccination with pneuomococcal vaccine), @risk of acute sicking complications with GA, pre/peri op Mx ?exchange transfusion, ensure adequate pain relief
Management of pt with suspected complications
- IVF
- adequate pain relief with optiates
- O2
- early ABx therapy is suspected infection
Haemostasis
- 3 elements:
- vasoconstriction
- vessel injury + vasoconstrictive elements from platelets + (pain ->) reflex sympathetic vasocontriction
- platelet aggregation
- platelets are formed in BM from megakaryocytes. Contain contractile proteins e.g. actin and myosin, no nucleus, endoplasmic reticulum and golgi apparatus -> proteins, mitochondria -> ATP/ADP. Synthesise prostaglandins and thromboxane A2. 1/2 life of 8-12 days. Tissue damage -> plts aggregation -> plt plug & adhere to damaged endothelium via von willebrand factor. Aggregating platelets release arachadonic acid which is converted to thromboxane A2. Ca mediate contraction of actin and myosin -> degranulation. Release of ADP -> further aggregation, positive feedback fashion
- clotting cascade
- 2x semi independent pathways; intrinsic (within bld, slow 2-6mins), extrinsic (fast 15secs, triggered by extravascular tissue damage, activated by exposure to tissue factor). Both pathways -> acivtation of prothrombin (Factor II) -common pathway-> fibrinogen converted to fibrin monomers which polymerise -> long fine strangds held together by H bonds later converted to covalent bonds with stabilisation of the fibrin polymer.
- vasoconstriction
Prothrombin time - PT
- Measure of extrinsic and common pathways
- add thromboplastin and calcium to the patients plasma
- PT is expressed as a ratio aka International Normalise Ratio.
- Prolonged in:
- Warfarin Treatment
- Liver disease
- Vit K deficiency
Activated partial thromboplastin time - APTT
- Tests intrinsic and common pathways
- Add Kaolin to pt plasma
- Prolonged in:
- Heparin treatment
- Haemophilia & factor deficiencies
- Liver disease
- Disseminated intravascular coagulation
- Massive transfusion
- Lupus anticoagulation
thrombin time
- Tests common pathway
- Thrombin is added to pt plasma
- converts fibrinogen into fibrin
- Prolonged in:
- heparin treatment
- DIC
- Dysfibrinogenaemia
Bleeding time
- measures capillary bleeding
- Prolonged in:
- Plt disorders
- vessel wall disorders
Bleeding diasthesis
- Vessel wall :
- Hereditary haemorrhagic telangiectasia
- Ehlers-Danlos syndrome
- Drugs e.g. steroids
- Sepsis
- Trauma
- Vasculitis
- Platelets
- Congenital plt disorders
- Thrombocytopenia
- Myeloproliferative disorders
- Drugs e.g. aspirin
- Coagulation system
- von Willebran’s disease
- Factor VII, IX deficiency (haemophilia)
- Liver disease
- Anticoagulants
- DIC
Haemophilia
- Haemophilia A = Factor VIII deficiency
- 1 in 10, 000 pop
- Haemophilia B = Christmas disease = Factor IX deficiency
- Sex linked disorder by c.1/3rd = no family Hx
- PC: childhood, prolonged haemorrage after dental extraction, recurrent haemarthroses/muscle haematomas, subperiosteal haemartomas -> haemophilic pseudo-tumours
- Severity correlated to clotting factor activity:
- <1% clotting factor activity -> severe disease with life-threatening bleeding
- 1-5% activity -> moderate disease with post traumatic bleeding
- 5-20% activity -> mild disease
- Ix: Prolonged APPT, Normal PT, BT prolonged, Factor VIII levels reduced
- Treatment:
- Factor VIII replacement either as F8 concentrate/cryoprecipirate
- bleeding is well controlled when FVIII levels >20%
- 5-10% pt develop antibodies to factor VIII and become refractory to replacement Rx
- Desmopressin -> increases intrinsic factor VIII levels
- Factor VIII replacement either as F8 concentrate/cryoprecipirate
von Willebrand’s disease
- Dysfunction/deficiency of vWF
- vWF -> mediates adhesion of plts to sites of vascular inj and bind & stabilises procoagulant protein factor VIII
- Haemostasis is imparied due to defective interaction between plts and vessel wall
- PC: skin bruising, node bleeds, haematoma, prolonged bleeding from trivial wounds
- Dx; demonstrate a deficiency of vWF
- Rx: desmopressing
Recombinant factor VIIa
- VIIa = Trypsin like serine protease = initiator of thrombin generation
- via 2 pathways -> activates factor Xa
- at site of tissue injury complexed with tissue factor
- TF found in subendothelial layer of vascular wall, not normally available to complex with factor VIIa but exposed following vessel wall injury
- on platelet surface independent of tissue factor
- at site of tissue injury complexed with tissue factor
- via 2 pathways -> activates factor Xa
- Recombinant VIIa - licensed for use in haemophiliacs with Abs to Factor VIII
Disseminated intravscular dissemindation
- widespread intravascular activation of the clotting cascade -> consumption of blotting factors -> bleeding tendency
- PC: bruising, purpura, oozing from surgical wounds/venepuncture
- Causes:
- Severe (usually gram neg/meningococcal) infection
- Widespread mucin-secreting metastatic adenocarcinoma
- Hypovolaemic shock
- Burns
- Transfusion reactions
- Eclampsia
- Amniotic fluid embolus
- Promyelocytic leukaemia
- Investigations:
- APPT andPT increased
- Serum fibrinogen levels reduced
- Fibrin degredation products increased
- Thrombocytopenia
- Factor V and VIII activities reduced
- Management:
- Fluid resuscitation
- Rx cause
- Clotting abnormalities corrected with FFP, cryoprecipitate and plt transfusion